You searched for "Enucleation"
Under pressure: a tool to aid the non-ophthalmic practitioner in the timely management of acute angle closure
Acute angle closure is a true ophthalmic emergency that mandates timely diagnosis and treatment. The priority in initial management is to lower the intraocular pressure in an expeditious matter using medical treatments. The risk of irreversible glaucomatous optic neuropathy is...The next wave of AI in ophthalmology: From screening to communication
Artificial intelligence (AI) is reshaping ophthalmology, moving from research laboratories into everyday clinical care [1]. With its strong reliance on imaging and pattern recognition, ophthalmology is uniquely positioned to benefit from AI innovations. These developments range from autonomous disease screening...Early bird bookings are open for Optometry Tomorrow 2024 – now incorporating BCLA Focus
Taking place from 28-29 April 2024, at the Telford International Centre, the flagship conference of The College of Optometrists now incorporates the biennial UK conference of the British Contact Lens Association.RCOphth (The Royal College of Ophthalmologists) TTT Supervision for Ophthalmic Practitioner Training (OPT)
This Training The Trainers course will help Trainers develop skills to manage trainees in or heading for difficulty. It will show how existing tools can be adapted to help, and give practice in the use of appropriate conversation techniques to...Ophthalmology in the Middle East: Reflections from two electives in Jordan and the UAE
In the summer of 2021, I was fortunate enough to embark on two electives in ophthalmology at the Shami Eye Centre in Amman, Jordan, and Moorfields Eye Hospital in Dubai, United Arab Emirates (UAE). These eye hospitals serve distinct populations,...Corporate M&A pace gathers momentum
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...A tale of two membranes
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...
